Efficacy and safety of surufatinib in patients with well-differentiated advanced extrapancreatic neuroendocrine tumors (NETs): Results from the randomized phase III study (SANET-ep)

Jihong Xu, Lin Shen, Zhiheng Zhou, Jiarui Li, Chunmei Bai, Z. Li, Nong Xu, Ru Jia, Elizabeth Li, Tianshu Liu,

Annals of Oncology · 2019 · 17 citations · 0 references

DOIFull text

Open access

Concepts